Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22778320 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Interventions: Drug: Bevacizumab;   Drug: Temozolomide

Study has passed its completion date and status has not been verified in more than two years.